News

Filter

Current filters:

None

Popular Filters

7870 to 7894 of 8833 results

Russia’s NSCLC market set to grow to $163 million in 2015

15-12-2011

The Russian market for non-small-cell lung cancer (NSCLC) therapies will grow 3% annually from 2010 to…

EuropeMarkets & MarketingOncologyPharmaceutical

HIV funding in developing countries needs more transparency; report

15-12-2011

With the need for HIV services in developing countries rising and the availability of funding flat or…

Anti-viralsFinancialHealthcarePharmaceutical

Boehringer expands in China; Lundbeckfond ups ALK-Abello stake

15-12-2011

Family-owned German drug major Boehringer Ingelheim says it intends to invest 70 million euros ($91 million)…

Alk-AbelloAsia-PacificBoehringer IngelheimEuropeFinancialLundbeckfondPharmaceutical

FDA advisory panel backs Alexza antipsychotic drug

15-12-2011

The US Food and Drug Administration’s Psychopharmacologic Drugs Advisory Committee (PDAC) has voted…

AdasuveAlexza PharmaceuticalFinancialLoxapineNeurologicalPharmaceuticalRegulation

Onyx joins with MMRF to advance MM targeted therapies

15-12-2011

US biotech firm Onyx Pharmaceuticals (Nasdaq: ONXX) has joined forces with the Multiple Myeloma Research…

BiotechnologyNorth AmericaOncologyOnyx PharmaceuticalsPharmaceuticalResearch

BioLineRx inks deal with Compugen

14-12-2011

Israeli biopharma company BioLineRx (TASE: BLRX) has entered into a collaboration with fellow Israel-based…

BioLineRxBiotechnologyCardio-vascularCompugenInflammatory diseasesLicensingOncologyPharmaceuticalResearch

More news briefs from ASH meeting

14-12-2011

In ongoing news from the American Society of Hematology (ASH) meeting taking place in San Diego, Swiss…

AmgenBiotechnologydaratumumabExjadeGenmabMerck & CoNovartisNplateOncologyPharmaceuticalResearchZolinza

Outlook for VTE treatment and prophylaxis market

14-12-2011

Driven primarily by the launches and strong uptake of oral anticoagulants, the combined markets for drugs…

BayerBristol-Myers SquibbCardio-vascularEliquisJohnson & JohnsonMarkets & MarketingPfizerPharmaceuticalXarelto

Australia’s generics sector stresses need for sustainable PBS

14-12-2011

Ensuring the Pharmaceutical Benefits Scheme (PBS) is sustainable and medicines remain affordable and…

Asia-PacificGenericsHealthcarePoliticsPricing

Global ADHD market set to grow at a CAGR of 8% to 2018

14-12-2011

The global attention deficit hyperactivity disorder (ADHD) therapeutics market was valued at $3.86 billion…

DaytranaGlobalIntunivMarkets & MarketingNeurologicalPharmaceuticalShireVyvanse

FTC stipulates divestments for Valeant acquisitions

14-12-2011

Canada’s Valeant Pharmaceuticals International (TSX: VRX) has been ordered by the USA’s Federal…

DermatologicalsDermikMergers & AcquisitionsNorth AmericaPharmaceuticalValeant Pharmaceuticals

Baxter to acquire Synovis

14-12-2011

The USA’s Baxter International (NYSE: BAX) said yesterday that it has reached agreement to acquire…

Baxter InternationalMergers & AcquisitionsPharmaceuticalSynovis Life Technologies

Mixed NICE views on Faslodex and RoActemra

14-12-2011

There was mixed news this morning from the UK’s National Institute for Health and Clinical Excellence…

Anti-Arthritics/RheumaticsAstraZenecaEuropeFaslodexOncologyPharmaceuticalPricingRegulationRoActemraRoche

SEC says GSK unit CEO defrauded shareholders

14-12-2011

The USA’s Securities and Exchange Commission says it has charged a subsidiary of UK pharma giant…

FinancialGlaxoSmithKlineLegalNorth AmericaPharmaceuticalStiefel

More news for ASH meeting

13-12-2011

In continuing news from the 53rd annual meeting of the American Society of Hematology (ASH) in San Diego,…

Avila TherapeuticsGleevecNovartisOncologypacritinibPharmaceuticalResearchS*BIOTasigna

Ablynx earns milestone from Merck Serono

13-12-2011

Belgium’s Ablynx (Euronext Brussels: ABLX) says it will earn a 1 million-euro ($1.3 million) from…

AblynxBiotechnologyFinancialImmunologicalsMerck KGaAMerck SeronoPharmaceuticalResearch

AstraZeneca sells imaging agent rights

13-12-2011

Anglo-Swedish drug major AstraZeneca (LSE: AZN) has out-licensed AZD4694, its late-stage radiopharmaceutical…

AstraZenecaLicensingNeoprobeNeurologicalPharmaceutical

First US cell-based flu vaccine plant

13-12-2011

Under a public-private partnership of the US Department of Health and Human Services and Novartis Vaccines…

Markets & MarketingNorth AmericaNovartisPharmaceuticalVaccines

Actelion pulls out of Trophos option

13-12-2011

Switzerland-based Actelion (SIX: ATLN), Europe’s biggest biotech company, says that it has decided…

ActelionBiotechnologyLicensingMergers & AcquisitionsolesoximePharmaceuticalRare diseasesTrophos

Onyx falls as FDA says no priority review for cancer drug

13-12-2011

US drugmaker Onyx Pharmaceuticals (Nasdaq: ONXX) saw its shares fall 7.1% to $37.76 in early trading…

carfilzomibNorth AmericaOncologyOnyx PharmaceuticalsPharmaceuticalRegulation

7870 to 7894 of 8833 results

Back to top